JOSHUA MATTHEWS: Open Payments
NPI 1194720169 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,703 in 108 payments from 14 companies in 2025. Trend: 2023 $1,212 · 2024 $1,755 · 2025 $2,703
Food & beverage: $2,703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $793 |
| Novartis Pharmaceuticals Corporation | 13 | $385 |
| GENZYME CORPORATION | 11 | $341 |
| Lilly USA, LLC | 10 | $341 |
| Janssen Biotech, Inc. | 19 | $293 |
| LEO Pharma Inc. | 7 | $144 |
| Amgen Inc. | 4 | $90 |
| UCB, Inc. | 5 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $59 |
| Incyte Corporation | 2 | $51 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, COSENTYX, TREMFYA, TALTZ, ADBRY, OTEZLA.
Industry payments across AR — which companies pay providers there.
